Malory Weber

578 total citations
14 papers, 358 citations indexed

About

Malory Weber is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Malory Weber has authored 14 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Malory Weber's work include Multiple Sclerosis Research Studies (4 papers), Ion Transport and Channel Regulation (2 papers) and Paraoxonase enzyme and polymorphisms (2 papers). Malory Weber is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Ion Transport and Channel Regulation (2 papers) and Paraoxonase enzyme and polymorphisms (2 papers). Malory Weber collaborates with scholars based in United States, Russia and Germany. Malory Weber's co-authors include W.H. Wilson Tang, Marisa McGinley, Vasiliki V. Georgiopoulou, Yuping Wu, Muhammad Hammadah, Daniel Ontaneda, Thomas Illig, Katharina Heim, Eva Lattka and Gabriele Moeller and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Malory Weber

14 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malory Weber United States	11	119	69	54	40	39	14	358
Uzay Görmüş Türkiye	16	235 2.0×	86 1.2×	48 0.9×	37 0.9×	27 0.7×	53	591
Clintoria R. Williams United States	14	172 1.4×	35 0.5×	52 1.0×	21 0.5×	98 2.5×	32	517
Kirill V. Savostyanov Russia	13	162 1.4×	50 0.7×	35 0.6×	47 1.2×	11 0.3×	102	585
Yoshinaga Otaki Japan	15	83 0.7×	26 0.4×	31 0.6×	30 0.8×	72 1.8×	29	609
Kazuhiko Matsuzawa Japan	12	158 1.3×	53 0.8×	35 0.6×	26 0.7×	12 0.3×	30	452
Rosario Liguori Italy	12	191 1.6×	29 0.4×	28 0.5×	30 0.8×	37 0.9×	15	450
Arianna Maiorana Italy	17	226 1.9×	19 0.3×	45 0.8×	130 3.3×	59 1.5×	52	839
Sun Ha Lee South Korea	11	155 1.3×	26 0.4×	38 0.7×	54 1.4×	18 0.5×	16	406
Mitsuharu Narita Japan	12	110 0.9×	92 1.3×	15 0.3×	34 0.8×	16 0.4×	31	490
Elizabeth Rubin United States	9	139 1.2×	77 1.1×	23 0.4×	14 0.3×	36 0.9×	15	346

Countries citing papers authored by Malory Weber

Since Specialization

Citations

This map shows the geographic impact of Malory Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malory Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malory Weber more than expected).

Fields of papers citing papers by Malory Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malory Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malory Weber. The network helps show where Malory Weber may publish in the future.

Co-authorship network of co-authors of Malory Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Malory Weber. A scholar is included among the top collaborators of Malory Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malory Weber. Malory Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

McGinley, Marisa, Daniel Ontaneda, Malory Weber, et al.. (2020). Teleneurology as a Solution for Outpatient Care During the COVID-19 Pandemic. Telemedicine Journal and e-Health. 26(12). 1537–1539. 37 indexed citations

Rao, Stephen M., Rachel Galioto, Mark Sokolowski, et al.. (2020). Multiple Sclerosis Performance Test: validation of self‐administered neuroperformance modules. European Journal of Neurology. 27(5). 878–886. 35 indexed citations

Baldassari, Laura, Kunio Nakamura, Brandon Moss, et al.. (2019). Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice. Multiple Sclerosis and Related Disorders. 38. 101525–101525. 15 indexed citations

Miller, Deborah, Brandon Moss, Susannah Rose, et al.. (2019). Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported Outcomes. SHILAP Revista de lepidopterología. 7(4). 541–548. 7 indexed citations

McGinley, Marisa, Nicolas R. Thompson, Malory Weber, Robert Bermel, & Daniel Ontaneda. (2019). Trends in the use of Highly Effective Disease Modifying Treatments in Multiple Sclerosis over 12 years across 10 Sites (S26.003). Neurology. 92(15_supplement). 2 indexed citations

Li, Wei, David J. Kennedy, Zhili Shao, et al.. (2018). Paraoxonase 2 prevents the development of heart failure. Free Radical Biology and Medicine. 121. 117–126. 23 indexed citations

Kennedy, David J., Brendan Sheehy, Malory Weber, et al.. (2018). Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na+/K+-ATPase Profibrotic Signaling Pathways. International Journal of Molecular Sciences. 19(9). 2566–2566. 24 indexed citations

Hammadah, Muhammad, Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, et al.. (2017). High-Density Lipoprotein-Associated Paraoxonase-1 Activity for Prediction of Adverse Outcomes in Outpatients with Chronic Heart Failure. European Journal of Heart Failure. 19(6). 748–755. 25 indexed citations

Hammadah, Muhammad, Vasiliki V. Georgiopoulou, Andreas P. Kalogeropoulos, et al.. (2015). Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure. Circulation Heart Failure. 9(1). e002115–e002115. 36 indexed citations

10.

Kennedy, David J., Malory Weber, Anuradha Guggilam, et al.. (2014). Abstract 17746: Telecinobufagin, a Novel Cardiotonic Steroid, Promotes Myocardial and Renal Fibrosis via Na/K-ATPase Profibrotic Signalling Pathways. Circulation. 130(suppl_2). 2 indexed citations

11.

Kerr, Bethany A., Xiaoxia Z. West, Liang Ding, et al.. (2013). Interference with Akt Signaling Protects Against Myocardial Infarction and Death by Limiting the Consequences of Oxidative Stress. Science Signaling. 6(287). ra67–ra67. 31 indexed citations

12.

West, Xiaoxia Z., Nahum Meller, Nikolay Malinin, et al.. (2012). Integrin β3 Crosstalk with VEGFR Accommodating Tyrosine Phosphorylation as a Regulatory Switch. PLoS ONE. 7(2). e31071–e31071. 34 indexed citations

13.

Raman, Priya, et al.. (2010). A Novel Transcriptional Mechanism of Cell Type–Specific Regulation of Vascular Gene Expression by Glucose. Arteriosclerosis Thrombosis and Vascular Biology. 31(3). 634–642. 22 indexed citations

14.

Lattka, Eva, Stefanie Eggers, Gabriele Moeller, et al.. (2009). A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor ELK1. Journal of Lipid Research. 51(1). 182–191. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact